MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 124 filers reported holding MERSANA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,217,717 | -12.3% | 378,450 | +1.2% | 0.01% | -7.7% |
Q3 2022 | $2,528,000 | +21.7% | 373,895 | -16.8% | 0.01% | +30.0% |
Q2 2022 | $2,077,000 | +61.1% | 449,661 | +39.2% | 0.01% | +150.0% |
Q1 2022 | $1,289,000 | -9.3% | 323,068 | +41.4% | 0.00% | 0.0% |
Q4 2021 | $1,421,000 | – | 228,490 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 4,005,600 | $64,810,000 | 6.21% |
Bain Capital Life Sciences Investors, LLC | 3,695,667 | $59,796,000 | 3.39% |
COMMODORE CAPITAL LP | 429,228 | $6,945,000 | 2.77% |
ACUTA CAPITAL PARTNERS, LLC | 357,689 | $5,787,000 | 2.09% |
Avoro Capital Advisors LLC | 6,800,000 | $110,024,000 | 1.90% |
Ghost Tree Capital, LLC | 450,000 | $7,281,000 | 1.71% |
RHO CAPITAL PARTNERS INC | 796,458 | $12,887,000 | 1.24% |
Rock Springs Capital Management LP | 2,775,127 | $44,902,000 | 0.98% |
Sio Capital Management, LLC | 157,259 | $2,544,000 | 0.52% |
Bellevue Group AG | 2,850,010 | $46,113,000 | 0.49% |